Business Segments · Sales and marketing

Business Segments — Sales and marketing

Amgen Business Segments — Sales and marketing increased by 3.4% to $1.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from $1.07B to $1.13B.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026

How to read this metric

Rising costs may be necessary for new product launches, but sustained increases without revenue growth suggest declining marketing efficiency.

Detailed definition

Includes costs related to the promotion, advertising, and sales force activities required to commercialize the company's...

Peer comparison

Standard 'Selling, General, and Administrative' (SG&A) component across the industry.

Metric ID: amgn_segment_reportable_segment_sales_and_marketing

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$1.20B$1.21B$1.12B$1.07B$1.14B$1.10B$1.13B
QoQ Change+0.6%-7.8%-4.6%+6.7%-3.5%+3.4%
YoY Change-11.5%-6.1%-1.8%+6.4%
Range$1.07B$1.21B
CAGR-3.9%
Avg YoY Growth-3.2%
Median YoY Growth-4.0%

Frequently Asked Questions

What is Amgen's business segments — sales and marketing?
Amgen (AMGN) reported business segments — sales and marketing of $1.13B in Q1 2026.
How has Amgen's business segments — sales and marketing changed year-over-year?
Amgen's business segments — sales and marketing increased by 6.4% year-over-year, from $1.07B to $1.13B.
What does business segments — sales and marketing mean?
The costs associated with promoting and selling the company's products to healthcare providers and patients.